A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia.
| Author | |
|---|---|
| Abstract | :  Iron deficiency anaemia is common in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) and is often treated with oral or intravenous (IV) iron therapy. This trial compared the efficacy and safety of IV iron isomaltoside 1000 (MonoferĀ®) and oral iron in NDD-CKD patients with renal-related anaemia. | 
| Year of Publication | :  2016 | 
| Journal | :  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 
| Volume | :  31 | 
| Issue | :  4 | 
| Number of Pages | :  646-55 | 
| ISSN Number | :  0931-0509 | 
| URL | :  https://academic.oup.com/ndt/article-lookup/doi/10.1093/ndt/gfv293 | 
| DOI | :  10.1093/ndt/gfv293 | 
| Short Title | :  Nephrol Dial Transplant | 
| Download citation |